| Kristie May Chu, MD | |
|
10905 Memorial Hermann Dr Ste 111, Pearland, TX 77584-3490 | |
| (281) 929-4727 | |
| (281) 929-4728 |
| Full Name | Kristie May Chu |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 9 Years |
| Location | 10905 Memorial Hermann Dr Ste 111, Pearland, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780078089 | NPI | - | NPPES |
| S5583 | Other | TX | STATE LICENSE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann Hospital System | Houston, TX | Hospital |
| Midland Memorial Hospital | Midland, TX | Hospital |
| Memorial Hermann - Texas Medical Center | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mhs Physicians Of Texas | 1557254968 | 71 |
| Premier Family Care I, Inc | 2567351372 | 60 |
News Archive
The Journal of Exposure Science and Environmental Epidemiology last week revealed the findings of a 2016 pilot study that measured pregnant women's exposure to environmental contaminants in northeastern British Columbia, an area of intensive natural-gas production through hydraulic fracturing.
More than 200 experts will gather at Clemson University's Madren Conference Center Feb. 6-9 to explore the value of play, and they already agree on one thing: Children don't get outside enough.
A Research and Development group led by Professor Yoshifumi Saijo of Tohoku University and Noriyuki Masuda of Advantest has succeeded in developing in vivo skin imaging technology that can simultaneously generate dual-wavelength photoacoustic images and ultrasound images.
The Food and Drug Administration (FDA) has announced the licensing of a new vaccine against a disease responsible for tens of thousands of hospitalizations in the United States and hundreds of thousands of deaths around the world each year.
Under a $10 million grant, a randomized, placebo-controlled clinical trial led by Boston Children's Hospital will test a personalized treatment for a form of severe asthma to which Black and Latinx children and adults are especially vulnerable.
› Verified 6 days ago
| Entity Name | Mhs Physicians Of Texas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184714867 PECOS PAC ID: 1557254968 Enrollment ID: O20040207000177 |
News Archive
The Journal of Exposure Science and Environmental Epidemiology last week revealed the findings of a 2016 pilot study that measured pregnant women's exposure to environmental contaminants in northeastern British Columbia, an area of intensive natural-gas production through hydraulic fracturing.
More than 200 experts will gather at Clemson University's Madren Conference Center Feb. 6-9 to explore the value of play, and they already agree on one thing: Children don't get outside enough.
A Research and Development group led by Professor Yoshifumi Saijo of Tohoku University and Noriyuki Masuda of Advantest has succeeded in developing in vivo skin imaging technology that can simultaneously generate dual-wavelength photoacoustic images and ultrasound images.
The Food and Drug Administration (FDA) has announced the licensing of a new vaccine against a disease responsible for tens of thousands of hospitalizations in the United States and hundreds of thousands of deaths around the world each year.
Under a $10 million grant, a randomized, placebo-controlled clinical trial led by Boston Children's Hospital will test a personalized treatment for a form of severe asthma to which Black and Latinx children and adults are especially vulnerable.
› Verified 6 days ago
| Entity Name | Premier Family Care I, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275522864 PECOS PAC ID: 2567351372 Enrollment ID: O20040311000343 |
News Archive
The Journal of Exposure Science and Environmental Epidemiology last week revealed the findings of a 2016 pilot study that measured pregnant women's exposure to environmental contaminants in northeastern British Columbia, an area of intensive natural-gas production through hydraulic fracturing.
More than 200 experts will gather at Clemson University's Madren Conference Center Feb. 6-9 to explore the value of play, and they already agree on one thing: Children don't get outside enough.
A Research and Development group led by Professor Yoshifumi Saijo of Tohoku University and Noriyuki Masuda of Advantest has succeeded in developing in vivo skin imaging technology that can simultaneously generate dual-wavelength photoacoustic images and ultrasound images.
The Food and Drug Administration (FDA) has announced the licensing of a new vaccine against a disease responsible for tens of thousands of hospitalizations in the United States and hundreds of thousands of deaths around the world each year.
Under a $10 million grant, a randomized, placebo-controlled clinical trial led by Boston Children's Hospital will test a personalized treatment for a form of severe asthma to which Black and Latinx children and adults are especially vulnerable.
› Verified 6 days ago
| Entity Name | Round Table Specialist Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497152268 PECOS PAC ID: 1254754609 Enrollment ID: O20200702000716 |
News Archive
The Journal of Exposure Science and Environmental Epidemiology last week revealed the findings of a 2016 pilot study that measured pregnant women's exposure to environmental contaminants in northeastern British Columbia, an area of intensive natural-gas production through hydraulic fracturing.
More than 200 experts will gather at Clemson University's Madren Conference Center Feb. 6-9 to explore the value of play, and they already agree on one thing: Children don't get outside enough.
A Research and Development group led by Professor Yoshifumi Saijo of Tohoku University and Noriyuki Masuda of Advantest has succeeded in developing in vivo skin imaging technology that can simultaneously generate dual-wavelength photoacoustic images and ultrasound images.
The Food and Drug Administration (FDA) has announced the licensing of a new vaccine against a disease responsible for tens of thousands of hospitalizations in the United States and hundreds of thousands of deaths around the world each year.
Under a $10 million grant, a randomized, placebo-controlled clinical trial led by Boston Children's Hospital will test a personalized treatment for a form of severe asthma to which Black and Latinx children and adults are especially vulnerable.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristie May Chu, MD 10905 Memorial Hermann Dr Ste 111, Pearland, TX 77584-3490 Ph: (281) 929-4727 | Kristie May Chu, MD 10905 Memorial Hermann Dr Ste 111, Pearland, TX 77584-3490 Ph: (281) 929-4727 |
News Archive
The Journal of Exposure Science and Environmental Epidemiology last week revealed the findings of a 2016 pilot study that measured pregnant women's exposure to environmental contaminants in northeastern British Columbia, an area of intensive natural-gas production through hydraulic fracturing.
More than 200 experts will gather at Clemson University's Madren Conference Center Feb. 6-9 to explore the value of play, and they already agree on one thing: Children don't get outside enough.
A Research and Development group led by Professor Yoshifumi Saijo of Tohoku University and Noriyuki Masuda of Advantest has succeeded in developing in vivo skin imaging technology that can simultaneously generate dual-wavelength photoacoustic images and ultrasound images.
The Food and Drug Administration (FDA) has announced the licensing of a new vaccine against a disease responsible for tens of thousands of hospitalizations in the United States and hundreds of thousands of deaths around the world each year.
Under a $10 million grant, a randomized, placebo-controlled clinical trial led by Boston Children's Hospital will test a personalized treatment for a form of severe asthma to which Black and Latinx children and adults are especially vulnerable.
› Verified 6 days ago
Tiffany Cossey, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10905 Memorial Hermann Dr Ste 111, Pearland, TX 77584 Phone: 281-929-4727 Fax: 281-929-4728 | |
Dr. Rebecca Helena Maxwell, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3518 Brandemere Dr, Pearland, TX 77584 Phone: 713-598-6265 Fax: 281-485-9089 | |
Leah Quezada Kolar Onoja, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7501 Fite Rd, Pearland, TX 77584 Phone: 281-997-5515 | |
Dr. Chiyyarath V Sathees, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2225 County Road 90, Suite 201 G, Pearland, TX 77584 Phone: 832-654-4390 Fax: 281-265-2751 | |
Lynette M Gogol, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2225 County Rd 90, Suite 107, Pearland, TX 77584 Phone: 281-485-2337 Fax: 281-485-2985 | |
Dr. Irina Digilova, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6302 West Broadway Street, Suite 230, Pearland, TX 77581 Phone: 281-529-6242 Fax: 281-741-4104 | |
Dr. Kathleen H. Eberle, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10905 Memorial Hermann Dr, Ste 115, Pearland, TX 77584 Phone: 713-947-3100 Fax: 713-704-1796 |